Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 601 AL 615

Management of Alzheimer's Disease With Nanotechnological Interventions and Novel Therapeutics

Shahrukh M, Ahmad S, Zaafar M, Hasan N, Ahmad FJ.

Drug Dev Res. 2025 Aug;86(5):e70120. doi: 10.1002/ddr.70120.

The potential role of aryl hydrocarbon receptor in Alzheimer's disease: Protective or detrimental

Al-Kuraishy HM, Al-Maiahy TJ, Sulaiman GM, Mohammed HA, Albuhadily AK, Al-Gareeb AI, Abomughaid MM.

Ageing Res Rev. 2025 Aug;110:102810. doi: 10.1016/j.arr.2025.102810. Epub 2025 Jun 17.

Astrocytic lipidopathy and bioenergetic failure in ApoE4-associated late-onset Alzheimer's disease: A unifying hypothesis

Garrahy JP.

J Alzheimers Dis. 2025 Aug;106(3):890-902. doi: 10.1177/13872877251350338. Epub 2025 Jun 26.

The Clinical Trials Landscape for Alzheimer's Disease

Shen G, Xu X, Li M, Sun Z, Wei L, Deng Z, Lin Z, Huang J, Qi W, Xu J.

CNS Neurosci Ther. 2025 Jun;31(6):e70492. doi: 10.1111/cns.70492.

The Inflammasome-miR Axis in Alzheimer's Disease and Chronic Pain: Molecular Mechanisms and Therapeutic Opportunities

Gaál B, Takács R, Matta C, Juhász K, Fülesdi B, Szekanecz Z, Benkő S, Ducza L.

Aging Dis. 2025 May 21;17(3):1190-1223. doi: 10.14336/AD.2025.0353.

Plant-based flavonoids and their nanoparticles: Latest arsenal against Alzheimer's disease

Kumbhar PS, Kolekar KA, Vishwas S, Kamble V, Bashir B, Patil KS, Bhagwat D, Gupta G, Prasher P, Singh M, Singh SK, Disouza J, Patravale VB.

Drug Deliv Transl Res. 2025 Dec;15(12):4411-4451. doi: 10.1007/s13346-025-01906-9. Epub 2025 Jun 30.

Klotho protein in Alzheimer's disease: Diet leading to immortality?

Walczak K, Kołodziejczyk W, Pszczołowska M, Kozłowska M, Beszłej JA, Leszek J.

J Alzheimers Dis. 2025 Aug;106(3):823-831. doi: 10.1177/13872877251350125. Epub 2025 Jul 1.

Milestone Review: The History of Molecular Genetics Analysis of Alzheimer's Disease

Hardy J.

J Neurochem. 2025 Jul;169(7):e70148. doi: 10.1111/jnc.70148.

The aggregation propensity of Tau and amyloid-β in Alzheimer's disease

Chinnathambi S, Kumarappan M, Chandrashekar M, Malik S.

Adv Protein Chem Struct Biol. 2025;146:179-199. doi: 10.1016/bs.apcsb.2024.10.004. Epub 2025 Apr 2.

Small-diffusible aggregates, plaques, tangles, and dynamic equilibria: Untangling Alzheimer's disease

Fertan E, Meisl G, Klenerman D.

Alzheimers Dement. 2025 Jul;21(7):e70462. doi: 10.1002/alz.70462.

Breaking the vicious cycle: bitter compounds targeting metabolic defects and inflammation in Alzheimer's disease

Wu H, He L, Dai L.

Am J Physiol Endocrinol Metab. 2025 Aug 1;329(2):E266-E275. doi: 10.1152/ajpendo.00166.2025. Epub 2025 Jul 7.

The close relationship between trace elements (Cu, Fe, Zn, Se, Rb, Si, Cr, and V) and Alzheimer's disease: Research progress and insights

Mao Y, Zhang L, Zhang C, Qin L, Liao X, Zhao L.

J Trace Elem Med Biol. 2025 Aug;90:127692. doi: 10.1016/j.jtemb.2025.127692. Epub 2025 Jul 3.

Gut microbiota-driven neuroinflammation in Alzheimer's disease: from mechanisms to therapeutic opportunities

Lei W, Cheng Y, Liu X, Gao J, Zhu Z, Ding W, Xu X, Li Y, Ling Z, Jiang R, Chen X.

Front Immunol. 2025 Jun 26;16:1582119. doi: 10.3389/fimmu.2025.1582119. eCollection 2025.

Natural Products and Exercise Synergy: Unraveling Molecular Mechanisms to Enhance Brain Function in Alzheimer's Disease

Chen L, Wang X, Zheng Q, Wang H.

Phytother Res. 2025 Aug;39(8):3800-3812. doi: 10.1002/ptr.70005. Epub 2025 Jul 11.

Glial Cells in Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Frontiers

Sil M, Mukherjee N, Chatterjee I, Ghosh A, Goswami A.

J Mol Neurosci. 2025 Jul 12;75(3):87. doi: 10.1007/s12031-025-02379-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias